El estado protrombótico en los pacientes con cáncer

Lluvia S. Sosa-Quintero, Ivette L. Carrasco-Martínez, Ignacio Mariscal-Ramírez, Eduardo E. García-Luna, Arnulfo H. Nava-Zavala, Benjamín Rubio-Jurado*

*Autor correspondiente de este trabajo

Producción científicarevisión exhaustiva

1 Cita (Scopus)


Cancer is an acquired prothrombotic state with an increased risk of thrombosis. Thromboembolic complications are the second cause of death, and pulmonary thromboembolism counts for about 50% of necropsies of cancer patients. In these patients, the prothrombotic state is a subclinical condition that is detected by the presence of an increase in serum fibrinogen levels, fibrin degradation products, coagulation factors such as factor V, VII, IX, X, and thrombocytosis, among others. In the cancer prothrombotic state, the biological mechanisms modify Virchow's triad elements, and cell activity, modify proteins, and neoplastic cells produce procoagulant molecules, fibrinolytic, and proinflammatory cytokines. The Khorana predictive model, which includes the measurement of biomarkers such as D dimer and P selectin, allows stratifying clinical risk. Prevention of venous thromboembolism in patients at higher risk could improve the response to treatment and survival. Therefore, properly designed studies should clarify the effect of thromboprophylaxis in these patients.
Título traducido de la contribuciónThe protrombotic state in patients with cancer
Idioma originalSpanish
Páginas (desde-hasta)26-34
Número de páginas9
PublicaciónGaceta Mexicana de Oncologia
EstadoPublished - ene 2021

Nota bibliográfica

Publisher Copyright:
© 2021 Publicaciones Permanyer. All rights reserved.

All Science Journal Classification (ASJC) codes

  • Oncología
  • Investigación sobre el cáncer


Profundice en los temas de investigación de 'El estado protrombótico en los pacientes con cáncer'. En conjunto forman una huella única.

Citar esto